These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9615199)

  • 1. Cell cycle regulators as prognostic factors for bladder cancer.
    Cordon-Cardo C
    Eur Urol; 1998; 33 Suppl 4():11-2. PubMed ID: 9615199
    [No Abstract]   [Full Text] [Related]  

  • 2. Bladder cancer: natural history, tumor markers, and early detection strategies.
    Foresman WH; Messing EM
    Semin Surg Oncol; 1997; 13(5):299-306. PubMed ID: 9259085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder.
    Grossfeld GD; Muscheck M; Stein JP; Chew K; Cote RJ; Ginsberg DA; Waldman FM; Carroll PR
    Adv Exp Med Biol; 1999; 462():425-35. PubMed ID: 10599445
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic factors in urothelial carcinoma].
    Vögeli TA; Ackermann R
    Urologe A; 2001 Nov; 40(6):442-6. PubMed ID: 11760346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular prognostic factors in bladder cancer.
    Schalken JA
    Eur Urol; 1998; 33 Suppl 4():13-4. PubMed ID: 9615200
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy: The development of immunotherapy in urothelial bladder cancer.
    Powles T
    Nat Rev Clin Oncol; 2015 Apr; 12(4):193-4. PubMed ID: 25781573
    [No Abstract]   [Full Text] [Related]  

  • 7. Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer.
    Mbeutcha A; Lucca I; Mathieu R; Lotan Y; Shariat SF
    Urol Clin North Am; 2016 Feb; 43(1):47-62. PubMed ID: 26614028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line.
    Aranha O; Wood DP; Sarkar FH
    Clin Cancer Res; 2000 Mar; 6(3):891-900. PubMed ID: 10741713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression.
    Yang CC; Chu KC; Chen HY; Chen WC
    Urol Int; 2002; 69(3):190-4. PubMed ID: 12372886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superficial bladder cancer: decreasing the risk of recurrence.
    Grossman HB
    Oncology (Williston Park); 1996 Nov; 10(11):1617-24; discussion 1624, 1627-8. PubMed ID: 8953583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular aspects of bladder cancer III. Prognostic markers of bladder cancer.
    Kausch I; Böhle A
    Eur Urol; 2002 Jan; 41(1):15-29. PubMed ID: 11999461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in diagnosis and therapy of transitional cell carcinoma of the bladder.
    Lerner SP
    Urol Oncol; 2006; 24(4):324-5. PubMed ID: 16818186
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent advances in diagnosis and treatment of transitional cell carcinoma of the bladder.
    Martyn-Hemphill C; Mak D; Khan MS; Challacombe BJ; Bishop CV
    Int J Surg; 2013; 11(9):749-52. PubMed ID: 24013072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting and treating bladder cancer.
    Anderson B
    Br J Nurs; 2013 Jun 13-26; 22(11):628. PubMed ID: 23899731
    [No Abstract]   [Full Text] [Related]  

  • 15. [Carcinoembryonic antigen in tumor tissue and urine in cases with primary bladder cancer--a study by immunogold-silver staining and radioimmunoassay].
    Kawano S
    Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):469-74. PubMed ID: 2464713
    [No Abstract]   [Full Text] [Related]  

  • 16. A case report and review of transitional cell carcinoma in children.
    Dai J; Caldamone AA; Ellermeier CJ; Ellsworth P
    Urol Nurs; 2014; 34(2):75-82. PubMed ID: 24919245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroids and gender differences in nonmuscle invasive bladder cancer.
    Lucca I; Fajkovic H; Klatte T
    Curr Opin Urol; 2014 Sep; 24(5):500-5. PubMed ID: 24978392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer of the urogenital tract: bladder cancer. The accuracy of clinical vs. surgical staging.
    Baker R
    JAMA; 1968 Nov; 206(8):1770-3 passim. PubMed ID: 5754828
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical and immunologic diagnosis of cancer. Renal and transitional carcinomas.
    Cordon-Cardo C
    Tumour Biol; 1987; 8(2-3):94-102. PubMed ID: 3329405
    [No Abstract]   [Full Text] [Related]  

  • 20. WAF1/p21 protein expression is an independent prognostic indicator in superficial and invasive bladder cancer.
    Korkolopoulou P; Konstantinidou AE; Thomas-Tsagli E; Christodoulou P; Kapralos P; Davaris P
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):285-92. PubMed ID: 11127920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.